The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain
Dominik Feuerbach(Novartis Institutes for BioMedical Research), Kurt Lingenhoehl(Novartis Institutes for BioMedical Research), Hans-Rudolf Olpe(Novartis Institutes for BioMedical Research), A. Vassout(Novartis Institutes for BioMedical Research), C. Gentsch(Novartis Institutes for BioMedical Research), Frédérique Chaperon(Novartis (Switzerland)), Joachim Nozulak(Novartis (Switzerland)), Albert Enz(Novartis (Switzerland)), Graeme Bilbe(Novartis (Switzerland)), Kevin H. McAllister(Novartis (Switzerland)), Daniël Hoyer(Novartis (Switzerland))
Cited by 127
Abstract
Related Papers
No related papers found
Powered by citation graph analysis